El Vínculo El Vínculo.
Awarded European Union SuppliesFramework agreement

Rekvisitionsläkemedel - Eribulin och Ustekinumab (Sydöstra-Ö)

Buyer: Region Östergötland

Published
13 March 2025
Estimated value
14,000,000 kr
Place of performance
SE123
Procedure
Open procedure
Notice number
00163529-2025
Reference
6b50f404-ab47-4fae-83b0-0fa975d47752
Official source
Official source

CPV codes

Description

Sydöstra sjukvårdsregionen (Region Östergötland, Region Jönköpings län, Region Kalmar län) inbjuder härmed till anbudsgivning avseende upphandling av rekvisitionsläkemedel: Eribulin (ATC-kod L01XX41) och Ustekinumab (ATC-kod L04AC05).

Lots (3)

LotDescriptionCPV codeAmount
1 Kvalificeringskrav
SE123
33600000 Productos farmacéuticos 14,000,000 kr
2 Anbudsområde 1: ACT-kod L04AC05 - Ustekinumab
SE123
33600000 Productos farmacéuticos 14,000,000 kr
3 Anbudsområde 2: ACT-kod L01XX41 - Eribulin
SE123
33600000 Productos farmacéuticos 14,000,000 kr

Award criteria

Awards

Awarded toAmountDate
Celltrion Sweden AB 3,649,190 kr
Celltrion Sweden AB 3,649,190 kr
Baxter Medical AB 983,280 kr
Baxter Medical AB 983,280 kr
Accord Healthcare AB
Amgen Aktiebolag
Abcur AB
Janssen-Cilag Aktiebolag
Glenmark Pharmaceuticals Nordic AB
BIOCON BIOLOGICS IRELAND LIMITED

Official publications

Other tenders from Region Östergötland

See all →

Frequently asked questions

What is the estimated value of this tender?
The estimated value published by the buyer is 14,000,000 kr.
Who is the buyer of this tender?
The contracting authority is Region Östergötland (European Union).
How can I bid for public tenders in European Union?
Bids are submitted through the official procurement portal of European Union. El Vínculo helps you find tenders and analyse their documents; submission always happens at the official source.
Get alerts for tenders like this
Create a free account and receive new tenders from European Union matching your business, every day.

Start for free

Data collected from official public procurement sources. Amounts as published by the buyer.